S. Venkateswara Rao, S. Sathesh Kumar
S. Venkateswara Rao1, S. Sathesh Kumar2*
1Department of Pharmaceutics, Vel’s Institute of Science, Technology and Advanced Studies (VISTAS), Vel’s University, Chennai–600117, Tamilnadu, India.
2School of Pharmaceutical Sciences, Vel’s Institute of Science, Technology and Advanced Studies (VISTAS), Vel’s University, Chennai–600117, Tamilnadu, India.
Volume - 14,
Issue - 7,
Year - 2021
The present work was aimed to prepare and evaluate Flutamide loaded methoxy poly (ethylene glycol) poly caprolactone (mPEG–PCL) nanoparticles for targeted delivery to the prostate cancer. The nanoparticles (NPs) were prepared by 23 factorial design and nanoprecipitation method. Various trials were evaluated for surface morphology, particle size and zeta potential. The influences of three formulation excipients such as polymer, stabilizer and organic phase volume on the characterization of NPs were investigated. The results of fourier transform infrared (FTIR) studies were indicated no interaction between the drug and polymer. The particle size varied from 79.2 to 89.1 nm and zeta potential value was found to be - 41.5 mv. The surface morphology of NPs was observed using scanning electron microscopy (SEM) and understands the arrangement and orientation of NPs to determine its behavior and stability. Flutamide loaded mPEG–PCL nanoparticle is a potential new carrier system for treatment of prostate cancer, which may overcome the problems associated with conventional formulations such as tablets.
Cite this article:
S. Venkateswara Rao, S. Sathesh Kumar. mPEG-PCL Nanoparticles as New Carriers for Delivery of a Prostae Cancer Drug Fluamide. Research Journal of Pharmacy and Technology. 2021; 14(7):3657-1. doi: email@example.com
S. Venkateswara Rao, S. Sathesh Kumar. mPEG-PCL Nanoparticles as New Carriers for Delivery of a Prostae Cancer Drug Fluamide. Research Journal of Pharmacy and Technology. 2021; 14(7):3657-1. doi: firstname.lastname@example.org Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-7-29
1. Mondrinos M. J, Dembzynski R., Byrapogu V. K, Wootton D. M, Lelkes P and Zhou J. Porogen based solid freeform fabrication of polycaprolactone calcium phosphate scaffolds for tissue engineering. Biomaterials. 2006; 27: 4399–4408.
2. Kim J and Bae Y. Albumin loaded microsphere of amphiphilic poly(ethylene glycol)/ poly(α-ester) multiblock copolymer. Eur J of Pharm Sci. 2004; 23: 245–251.
3. Hossein Danafar. MPEG–PCL copolymeric nanoparticles in drug delivery systems. Cogent Medicine. 2016; 3: 1 – 11
4. Huang M. H, Hutmacher D. W, Schantz J. T, Vacanti C. A, Braud C and Vert M. Degradation and cell culture studies on block copolymers prepared by ring opening polymerization of p-caprolactone in the presence of poly(ethylene glycol). J Biomed Mater Res. 2004; 69: 417–427.
5. Danafar H, Rostamizadeh K, Davaran S, Valizadeh H and Hamidi, M. Biodegradable m- PEG/PCL core- Shell Micelles: Preparation and characterization as a sustained release formulation for curcumin. Adv Pharm Bull. 2014; 4: 501–510.
6. Park E. K, Kim S. Y, Lee S. B and Lee Y. M. Folate conjugated methoxy poly(ethylene glycol)/poly(ɛcaprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery. J Control Release. 2005; 109: 158–168.
7. Chemical Structure of mPEG-PCL. https://www.google.com/ search?q =Chemical+Structure+of+mPEG-PCL
8. B. V. Nagarjuna yadav, V. Ravichandiran, S. Sathesh kumar. Preparation and characterization of gemcitabine loaded mpeg-pcl polymeric nanoparticles for improved transportation across blood brain barrier. IJPPS. 2016; 8: 82 – 90
9. Venkateswara Rao S, Sathesh Kumar S. Design and Evaluation of Flutamide-Loaded Polycaprolactone Nanoparticles by 23 Factorial Design and Nanoprecipitation Method. Asian J Pharm Clin Res. 2018; 11: 203-210
10. Dipsingh SN. Preparation and in vitro–in vivo evaluation of surface-modified poly(lactide-coglycolide) nanoparticles as controlled release carriers for flutamide delivery. J Microencapsul. 2015; 32: 231 – 239
11. R. S. Surenya, Snima, K. S., V Shantikumar, N., and Lakshmanan, V. Kumar. Assessment of Poly (vinyl alcohol) Coated Flutamide Nanoparticulates and Their Efficacy on Prostate Cancer Cells. Curr Drug Deliv. 2016; 2: 312 - 339
12. Ahmed O Elzoghby, Maged W Helmy, Wael M Samy and Nazik A Elgindy. Novel ionically crosslinked casein nanoparticles for flutamide delivery: formulation, characterization and in vivo pharmacokinetics. Int J Nanomedicine. 2013; 8: 1721–1732
13. Martel CL, Gumerlock PH, Meyers FJ and Lara PN. Current strategies in the management of hormone refractory prostate cancer. Cancer Treat Rev. 2003; 29: 171–187.
14. K. T. Arulmozhi and N. Mythili. Studies on the chemical synthesis and characterization of lead oxide nanoparticles with different organic capping agents. AIP Advances. 2013; 3: 122122 – 122129
15. Cegnar, M., Kos, J., Kristl, J. (2004) Cystatin incorporated in poly (lactide-co-glycolide) nanoparticles: development and fundamental studies on preservation of its activity. Eur J Pharm Sci. 22, pp. 357-364.